2016年欧洲肿瘤内科学会（ESMO）大会上我的个人亮点。
My personal highlights of ESMO 2016.
作者信息
Dediu M, Gerger A, Zojer N, Bartsch R
机构信息
Department of Oncology, Sanador Hospital, Bucharest, Romania.
Department of Medicine, Division of Oncology, Medical University of Graz, Graz, Austria.
出版信息
Memo. 2017;10(1):46-47. doi: 10.1007/s12254-017-0314-8. Epub 2017 Feb 8.
Abstract
Results of several clinically relevant studies were presented at the 2016 Annual Meeting of the European Society of Medical Oncology (ESMO). This article summerizes the personal highlights of three medical oncologists in their respective areas of expertise.
摘要
多项临床相关研究的结果在2016年欧洲医学肿瘤学会（ESMO）年会上公布。本文总结了三位医学肿瘤学家在各自专业领域的个人亮点。
相似文献
1
My personal highlights of ESMO 2016.2016年欧洲肿瘤内科学会（ESMO）大会上我的个人亮点。
Memo. 2017;10(1):46-47. doi: 10.1007/s12254-017-0314-8. Epub 2017 Feb 8.
2
ESMO 2017-my personal highlights.
Memo. 2018;11(1):77-79. doi: 10.1007/s12254-018-0385-1. Epub 2018 Feb 16.
3
Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO).欧洲医学肿瘤学会（ESMO）为年轻肿瘤学家提供的职业机会和福利。
ESMO Open. 2016 Dec 7;1(6):e000107. doi: 10.1136/esmoopen-2016-000107. eCollection 2016.
4
Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey.COVID-19 对女性肿瘤学家的影响是否大于男性？ESMO 女性肿瘤学（W4O）调查结果。
ESMO Open. 2021 Jun;6(3):100131. doi: 10.1016/j.esmoop.2021.100131. Epub 2021 May 25.
5
ESO-ESMO Masterclass in Clinical Oncology: Analysis and Evaluation of the Learning Self-Assessment Test.欧洲肿瘤内科学会-欧洲肿瘤外科学会临床肿瘤学大师班：学习自我评估测试的分析与评估。
J Cancer Educ. 2021 Jun;36(3):556-560. doi: 10.1007/s13187-019-01664-6.
6
Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.辅助化疗（CT）和放疗（RT）在未完全切除（R1）的早期非小细胞肺癌（NSCLC）中的应用：欧洲医学肿瘤学会（ESMO）青年肿瘤学家委员会进行的一项欧洲调查。
Lung Cancer. 2014 Jul;85(1):74-80. doi: 10.1016/j.lungcan.2014.03.010. Epub 2014 Mar 16.
7
New insights on personalized cancer treatments: a report from the ESMO Congress.个性化癌症治疗的新见解：来自 ESMO 大会的报告。
Expert Rev Anticancer Ther. 2011 Jan;11(1):21-3. doi: 10.1586/era.10.212.
8
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS.泛亚地区转移性结直肠癌管理的 ESMO 共识指南：日本临床肿瘤学会-欧洲肿瘤内科学会、韩国癌症学会、中国临床肿瘤学会、韩国肿瘤学会和日本肿瘤外科学会共同支持的一项 JSMO-ESMO 倡议。
Ann Oncol. 2018 Jan 1;29(1):44-70. doi: 10.1093/annonc/mdx738.
9
ESMO Designated Centres of Integrated Oncology and Palliative Care (ESMO DCs): education, research and programme development survey.ESMO 指定的综合肿瘤学和姑息治疗中心（ESMO DCs）：教育、研究和项目开发调查。
ESMO Open. 2022 Dec;7(6):100622. doi: 10.1016/j.esmoop.2022.100622. Epub 2022 Nov 7.
10
European Society for Medical Oncology (ESMO) Program for the integration of oncology and Palliative Care: a 5-year review of the Designated Centers' incentive program.欧洲肿瘤内科学会（ESMO）肿瘤与姑息治疗整合计划：指定中心激励计划的 5 年回顾。
Ann Oncol. 2010 Feb;21(2):362-369. doi: 10.1093/annonc/mdp318. Epub 2009 Aug 4.
本文引用的文献
1
Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial.卡博替尼对比舒尼替尼作为低危或中危转移性肾细胞癌患者的初始靶向治疗：联盟A031203 CABOSUN试验
J Clin Oncol. 2017 Feb 20;35(6):591-597. doi: 10.1200/JCO.2016.70.7398. Epub 2016 Nov 14.
2
Correction to Lancet Oncol 2015; 16: 522-30. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial.
Lancet Oncol. 2015 Jun;16(6):e262. doi: 10.1016/S1470-2045(15)70271-8. Epub 2015 May 27.
Zotero 插件